Connect your AI

Profound Medical PROF Increase (Decrease) in Accounts and Other Receivables

Increase (Decrease) in Accounts and Other Receivables at other companies

Lesaka Technologies, Inc.LSAK

-$12.61M-16.6%

Southern CopperSCCO

$65.1M-81.8%

PaccarPCAR

$279.1M+20.9%

Alpha CognitionACOG

-$657.96K-256%

VirnetX Holding Corp VHC

-$19K—

Siebert FinancialSIEB

$114K-41.5%

Other financials

Income statement

Revenue$5.3M+104%

Gross profit$3.8M+107%

Operating income-$8.0M+28.2%

Net income-$7.1M+34.2%

EPS (diluted)$0.19-47.2%

Balance sheet

Cash & equivalents$50.3M+8.3%

Total debt$7.5M+52.8%

Total equity$59.4M+17.0%

Total assets$73.5M+20.7%

Cash flow

Operating cash flow-$8.6M-3.6%

CapEx$44.0K—

Free cash flow-$9.6M—

Valuation

Market cap$241.65M+30.7%

Enterprise value$198.81M+28.7%

P/S12.8×-2.8×

Profitability

Gross margin71.1%+3.4pp

Operating margin-202.6%-51.3pp

Net margin-206.8%-39.0pp

FCF margin-238.4%—

Returns & leverage

Return on equity-70.6%+4.8pp

Debt / equity0.1×0.0×

Current ratio6.6×-4.8×

Where this comes from

Reported directly by Profound Medical in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables.

The official record: Profound Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Profound Medical's increase (decrease) in accounts and other receivables.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Profound Medical's increase (decrease) in accounts and other receivables?: Profound Medical (PROF) reported increase (decrease) in accounts and other receivables of $2.24M in Q1 2026.
How has Profound Medical's increase (decrease) in accounts and other receivables changed year-over-year?: Profound Medical's increase (decrease) in accounts and other receivables increased by 305.5% year-over-year, from -$1.09M to $2.24M.